Rani Therapeutics Holdings, Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · San Jose, CA
RANI chart
What traders are saying about $RANI
Latest postsRani Therapeutics Holdings, Inc. news
- Form 4 Rani Therapeutics Holdings Inc: Talat Imran (Director, CEO) For: 27 September
Investing.com India ·
- Chardan Capital maintains Buy rating on Rani Therapeutics Hldgs, $6 price target
TradingView ·
- Rani Therapeutics Eyes 2027 Obesity Data as Oral Biologics Platform Advances
marketbeat.com ·
- Rani Therapeutics at Chardan healthcare conference: platform gains traction By Investing.com
Investing.com Nigeria ·
- Rani Therapeutics to Participate in the Chardan Healthcare Conference
Yahoo Finance ·
- Rani Therapeutics Announces Acceptance into U.S. FDA's Emerging Technology Program (ETP)
Yahoo Finance ·
- Rani Therapeutics to Participate in Upcoming September Conferences
Yahoo Finance ·
- 3 Small Cap Biotech Stocks Trading At A Discount With Late Stage Clinical Catalysts
Yahoo Finance ·
- Rani Therapeutics Expands Oral Biologics Push With Obesity, Immunology Pipeline
marketbeat.com ·
- Rani Therapeutics Reports Second Quarter 2026 Financial Results; Provides Corporate Update
Yahoo Finance ·
- Rani Therapeutics Appoints Michelle Gilson to Board of Directors
Yahoo Finance ·
- Rani Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Yahoo Finance ·
Rani Therapeutics Holdings, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $1.6M | $1.0M | $0 | $0 |
| Net income | -$29.7M | -$30.0M | -$34.0M | -$30.6M |
| Diluted EPS | $-0.45 | $-1.05 | $-1.33 | $-1.28 |
| Total assets (year end) | $58.6M | $36.6M | $57.9M | $108.0M |
| Cash and equivalents (year end) | $18.6M | $3.8M | $5.9M | $27.0M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Rani Therapeutics Holdings, Inc.
- Ticker
- RANI (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- San Jose, CA
- Incorporated in
- CA
- Fiscal year end
- December 31
- SEC CIK
- 1856725
Frequently asked questions
What exchange is Rani Therapeutics Holdings, Inc. listed on?
Rani Therapeutics Holdings, Inc. trades on the Nasdaq under the ticker symbol RANI.
What industry is Rani Therapeutics Holdings, Inc. in?
Rani Therapeutics Holdings, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Rani Therapeutics Holdings, Inc. headquartered?
Rani Therapeutics Holdings, Inc.'s business address on file with the SEC is in San Jose, CA.
When does Rani Therapeutics Holdings, Inc.'s fiscal year end?
Rani Therapeutics Holdings, Inc.'s fiscal year ends on December 31.
How much revenue did Rani Therapeutics Holdings, Inc. report?
Rani Therapeutics Holdings, Inc. reported $1.6M in revenue for calendar year 2025, according to its SEC filings.